ESTIMATION OF THE EFFECTIVENESS OF FINANCIAL COSTS FOR TARGETED THERAPY OF PATIENTS WITH METASTATIC KIDNEY CANCER. (2018). Voprosy Onkologii, 64(5), 657-663. https://doi.org/10.37469/0507-3758-2018-64-5-657-663